Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent advances in pediatric oncology.

A M Mauer

    Pediatric Research
    |September 1, 1977
    PubMed
    Summary

    Advances in treating childhood cancer stem from clinical studies, but future breakthroughs require integrating laboratory research with clinical approaches. Understanding tumor biology is key for significant progress in pediatric oncology.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Phase II trial of oxaliplatin, leucovorin and fluorouracil in patients with advanced carcinoma of the esophagus.

    Annals of oncology : official journal of the European Society for Medical Oncology·2005
    Same author

    A phase II study of oxaliplatin and paclitaxel in patients with advanced non-small-cell lung cancer.

    Annals of oncology : official journal of the European Society for Medical Oncology·2004
    Same author

    A phase I study of STEALTH cisplatin (SPI-77) and vinorelbine in patients with advanced non small-cell lung cancer.

    Clinical lung cancer·2004
    Same author

    Phase I/II investigation of paclitaxel, ifosfamide and carboplatin for advanced non-small-cell lung cancer.

    Annals of oncology : official journal of the European Society for Medical Oncology·2003
    Same author

    A case study documenting the anticancer activity of ZD1839 (Iressa) in the brain.

    Annals of oncology : official journal of the European Society for Medical Oncology·2003
    Same author

    A pilot trial of G3139, a bcl-2 antisense oligonucleotide, and paclitaxel in patients with chemorefractory small-cell lung cancer.

    Annals of oncology : official journal of the European Society for Medical Oncology·2002

    Area of Science:

    • Pediatric Oncology
    • Cancer Biology
    • Clinical Therapeutics

    Background:

    • Significant progress has been made in treating childhood cancers, largely due to systematic clinical therapeutic studies.
    • Current understanding encompasses the natural history and some biological aspects of pediatric tumors.

    Purpose of the Study:

    • To highlight the evolution of pediatric cancer treatment strategies.
    • To identify future research directions for advancing pediatric cancer care.

    Main Methods:

    • Review of advancements in clinical therapeutic studies for childhood cancer.
    • Analysis of the current understanding of pediatric cancer biology and natural history.

    Main Results:

    • Clinical trials have markedly improved treatment outcomes for children with cancer.
    • Future major advances are anticipated from combined laboratory and clinical research, rather than solely from clinical trials.

    Conclusions:

    • Chemotherapy remains the primary treatment modality for pediatric cancers in the near future.
    • Enhanced understanding of childhood tumor biology is essential for significant therapeutic advancements.
    • Immunotherapy may offer future treatment options as knowledge in this area grows.

    Related Experiment Videos